5th ICHNO Programme Book

Podoplanin expression in oropharyngeal cancer influences staging and prognosis only in p16 negative tumours M.A. Broglie Daeppen (Switzerland), M. Roessle, S.Y. Kiessling, A. Soltermann, S.R. Haile, G.F. Huber, S.J. Stoeckli Reirradiation and cetuximab in patients with recurrent, unresectable previously irradiated head and neck cancer D. Milanovic (Germany), A.L. Grosu, M. Henke Comparison of VEGF expression in non malignant, premalignant lesion and squa- mous cell carcinoma of oral cavity M. Gupta (India), N. Husain, R. Mehrotra HPV 16 E7 seropositivity in head and neck squamous cell carcinoma compared to healthy controls T. Zahoor (United Kingdom), V. Green, N. Stafford, J. Greenman Clinical relevance of copy number abberrations in early (T1-2) oral cavity squamous cell carcinomas P. Van Kempen (The Netherlands), R. Noorlag, W. Braunius, C. Moelans, R. Koole, W. Grolman, R.J. Van Es, S.M. Willems The extracellular matrix in head and neck cancer at the leading edge of invasive growth E. Van Obberghen-Schilling (France), S. Beghelli-de la Forest Divonne, L. Veracini, S. Gopal, D. Grall, C. Butori, P. Hofman, A. Bozec, G. Orend, A. Sudaka Gain of copy number of PIK3CA and MET in head and neck cancers (HNSCCs) D. Brauswetter (Hungary), K. Danos, E. Birtalan, L. Tamas, I. Petak The role of circulating HPV-16 DNA detection in HNSCC patients treated by defini- tive radiation or chemo-radiation A.B. Hajduk (Poland), T. Rutkowski, A. Mazurek, K. Skladowski Prognostic value of Connexin 43 expression in head and neck cancers K. Dános (Hungary), D. Brauswetter, I. Peták, L. Tamás Excellent survival in patients with non-hypoxic, HPV-positive oropharyngeal squamous cell carcinoma J.E. Swartz (The Netherlands), A.J. Pothen, P.M.W. Van Kempen, I. Stegeman, S.M. Willems, W. Grolman

PO-101

PO-102

PO-103

PO-104

PO-105

PO-106

PO-107

PO-108

PO-109

PO-110

PROGRAMME & EXHIBITION GUIDE | POSTERS

29